Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep vein thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety - Colwell,C.W.; Spiro,T.E.; Trowbridge,A.A. (J Bone Joint Surg Am, 1994)